|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.79 USD | -0.21% |
|
-0.21% | +31.23% |
Transphorm, Inc. reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was USD 16.51 million compared to USD 24.05 million a year ago. Net loss was USD 30.6 million compared to USD 10.24 million a year ago.
Basic loss per share from continuing operations was USD 0.54 compared to USD 0.22 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +31.23% | 304M | |
| +152.82% | 2,971B | |
| +53.29% | 706B | |
| +33.98% | 677B | |
| +8.70% | 257B | |
| +48.92% | 233B | |
| +16.73% | 180B | |
| +107.05% | 150B | |
| +64.93% | 150B | |
| -38.79% | 132B |
TRANSPHORM, INC. 
